Blog

One team, one mission: nurturing a culture of innovation and collaboration

At BenevolentAI we believe that unconventional thinking combined with purposeful technology can lead to innovation that can truly change the world.

However, like all fast-growth companies, we face the challenge of balancing the need to build and scale quality products while also finding time to explore radical new ideas. We rose to the challenge the Benevolent way by creating Break-Out Week, a whole week dedicated to creativity and testing new ideas.

Over the course of the week, approximately 200 team members from across science, tech and business disciplines took part in 40 projects across our London, Cambridge and Brooklyn NY offices. Those from tech backgrounds would have been familiar with the concept of taking time out to explore ideas that are off the beaten track of day-to-day work, however this concept was less familiar for those with scientific backgrounds, for example our drug discoverers with extensive backgrounds in the pharmaceutical industry. And therein lies yet another challenge we face at Benevolent: bridging the traditional worlds of science and tech.

Our multidisciplinary squads cross the boundaries of tech and science, a combination which enables innovation, allows for quick experimentation and iterative feedback loops. However, this approach is not always easy, and we have spent a lot of time figuring out how to work together effectively and innovatively across disciplines.

With these challenges in mind, we created Break-Out Week with two very specific objectives:

1. To dedicate time apart from our day-to-day work to be curious and test new ideas, which is especially important in fields as fast paced as AI and machine learning.

2. To get to know one another better and work with new faces. We’ve been growing fast over the past few years, and as we have a unique way of working in our cross-collaborative squads, it’s important for us to understand each others complex backgrounds and specialisms and work together towards a common goal.

Break Out Week was the first event of its kind we’ve held at Benevolent, and was a uniquely collaborative effort. The event was planned, promoted and executed by an interdisciplinary team of volunteers, hailing from science, tech and business backgrounds. This set the week apart from a regular hackathon, since it was driven by those with their finger on the pulse of the company, the product being entirely unique to our culture and values.

Now onto the projects themselves. Some teams used Break-Out Week to grab the latest and greatest in research and test drive it on our problem. For instance, one project explored how we could use advances in Meta-Learning to learn better representations of molecules and quickly adapt our predictive models to new small datasets. Another project looked to characterise the diversity of our dataset to understand what groups are underrepresented and how that impacts our ability to treat patients equally… and the list goes on. These projects undoubtedly demonstrated how bringing diverse perspectives into the room can produce unexpected and remarkable results.

Break Out Week was also about fostering space for human connection, which is ultimately what drives our innovation and collaboration. We ate together as one big team everyday, and had activities including juice bikes and pot luck lunches. We even had a ball pit. Put simply, we had a lot of fun. Most importantly, the connections forged throughout the week brought a renewed energy and sense of togetherness, the legacy of which will help us drive forward our collective mission to deliver new and effective medicines to the patients who need them.

To create a culture of innovation, you must build and nurture an environment in which everyone is entrusted and empowered to innovate and bring value. Everyone means everyone, not just tech teams: including science, business and tech functions means you are able to generate unexpected and potentially game-changing ideas. Equally, innovation does not happen without learning, as is paramount in facilitating high quality ideas. Finally, nurturing a culture of innovation and collaboration means committing time to forge meaningful relationships, which unites us as one team with one mission: to unlock the power of scientific data to bring effective medicines to every patient.

Ben Medlock, CTO BenevolentAI

More Posts

You Might Also Like

Blog
Transforming drug discovery with AI: how we’re building and nurturing the best talent for the job
At BenevolentAI, we are on a mission to bring life-changing medicines to patients, and we are looking for collaborative, mission-driven people to join our tech, drug discovery and business operations teams in London, Cambridge and New York.
Oct 17, 2021
News
BenevolentAI identifies novel target for ulcerative colitis and advances candidate to IND/CTA-enabling studies
BenevolentAI’s AI-Drug Discovery platform uncovered a novel target not previously linked to ulcerative colitis and advanced candidate to preclinical studies.
Oct 14, 2021
Blog
Measuring bias: moving towards more inclusive health research outcomes #stateofai
Having shared our open-source Diversity Analysis Tool last year, we were tasked to investigate and demonstrate the lack of diversity in biomedical data as part of the State of AI Report 2021.
Oct 12, 2021
Blog
Expert-augmented computational drug discovery for rare diseases
Combining scientific expertise, computational tools and our AI-enhanced biomedical knowledge graph to successfully uncover a new drug combination for treating a rare brain cancer in children.
Sep 28, 2021
News
BenevolentAI appoints Dr John Orloff to its Board of Directors
Biopharmaceutical veteran Dr John Orloff joins the BenevolentAI Board as a Non-Executive Director as it scales the development of its leading AI-derived drug pipeline.
Sep 9, 2021
Blog
AI in Drug Discovery
This blog seeks to demystify the application of artificial intelligence (AI) and machine learning (ML) in drug discovery by exploring some of the challenges, opportunities and progress that has been achieved in the field so far.
Jul 13, 2021